Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Probiotics Market Revolution Needs Supplement Industry As Torchbearer

This article was originally published in The Tan Sheet

Executive Summary

Supplement firms should take the reins of probiotic research and promotion before the pharmaceutical industry controls the message, suggests Peter Leighton, Abunda Functional Foods CEO. Interest in manipulating the microbiome for therapeutic effect has garnered interest from pharma giants including J&J.


Related Content

Probiotic Beer Headed For Increasingly Specialized 'Good Bacteria' Market
Probiotic Claims Hit Regulatory Wall, But Media Gives An Advertising Lift


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts